Plunkett Research Online: Avexa Limited

AVEXA LIMITED (AVXAF) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Avexa Limited is an Australian biotechnology company with a focus on development and commercialization of small molecules for the treatment of infectious diseases. Its key anti-infective pharmaceutical programs and projects include apricitabine, an HIV integrase program and an antibiotic program for.....


AVEXA LIMITED

Ticker: AVXAF
Exchange: GREY
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 61 392084300
Fax: 61 392084004
Address: 576 Swan Street
Richmond, VIC 3121 Australia

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Avexa Limited is an Australian biotechnology company with a focus on development and commercialization of small molecules for the treatment of infectious diseases. Its key anti-infective pharmaceutical programs and projects include apricitabine, an HIV integrase program and an antibiotic program for.....See More See More

$USD, In whole numbers 2016201520142013201220112010
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture